88.24
19.26 (27.92%)
| Penutupan Terdahulu | 68.98 |
| Jumlah Dagangan | 3,952,848 |
| Harga / Pendapatan (P/E Ke hadapan) | 37.79 |
| Harga / Jualan (P/S) | 4.18 |
| Harga / Buku (P/B) | 4.86 |
| Julat 52 Minggu |
| Margin Keuntungan | 10.03% |
| Margin Operasi (TTM) | 19.12% |
| EPS Cair (TTM) | 1.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 48.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 110.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 194.67% |
| Nisbah Semasa (MRQ) | 9.10 |
| Aliran Tunai Operasi (OCF TTM) | 49.38 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -84.81 M |
| Pulangan Atas Aset (ROA TTM) | 4.21% |
| Pulangan Atas Ekuiti (ROE TTM) | 22.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | TransMedics Group, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Nilai 35% | 0.9 |
| AI Insight info | NA |
| Penilaian Relatif info | 2.0 |
| Kesihatan Kewangan info | -0.7 |
| Masa 35% | 2.2 |
| AI Technical info | NA |
| Osilator Teknikal info | 2.0 |
| Purata Bergerak Teknikal info | 2.5 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | 0.0 |
| Persekitaran | ×0.83 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -6.8% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 3.2 |
| Skor Akhir | 1.14 |
|
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.03% |
| % Dimiliki oleh Institusi | 121.56% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ARAUJO FERNANDO N. | 66.90 | - | 22,969 | 1,536,626 |
| Jumlah Keseluruhan Kuantiti Bersih | 22,969 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 1,536,626 | |||
| Purata Pembelian Keseluruhan ($) | 66.90 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| ARAUJO FERNANDO N. | Pegawai | 28 Oct 2026 | Diperolehi (+) | 22,969 | 66.90 | 1,536,626 |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |